Buscar resultados de ensayos clínicos
Cataplexy - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy Condición: Narcolepsy With Cataplexy Fecha: 2017-01-23 Intervenciones:
|
Recruiting |
Nombre del estudio: Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period Condición:
|
Completed |
Nombre del estudio: Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP) Condición:
Intervenciones: |
Completed |
Nombre del estudio: Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes Condición: Narcolepsy With Cataplexy Fecha: 2006-06-28 Intervenciones: Drug: Sodium Oxybate (Xyrem) Active Substance: Sodium Oxybate Pharmaceutical form: Oral Solution Concent |
Active, not recruiting |
Nombre del estudio: A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy Condición: Narcolepsy With Cataplexy Fecha: 2014-07-28 Intervenciones: Drug: Xyrem |
Completed |
Nombre del estudio: Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy Condición:
|
Recruiting |
Nombre del estudio: Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Condición:
|
Recruiting |
Nombre del estudio: Xyrem and Brain Dopamine in Narcolepsy Condición: Narcolepsy With Cataplexy Fecha: 2015-12-17 Intervenciones: Drug: Xyrem single 3.0 gram dose Other Names: |
Completed |
Nombre del estudio: Single-dose Safety Study of APD916 in Healthy Volunteers Condición: Narcolepsy With or Without Cataplexy Fecha: 2010-03-24 Intervenciones: Drug: APD916 |
Completed |
Nombre del estudio: Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant) Condición:
Fecha: 2011-06-21 Intervenciones: Drug: BF2.649 5,10,20,or 40 mg per day, in a once daily scheme |